ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $47,789,000 | -7.3% | 1,189,393 | -3.0% | 0.07% | -1.4% |
| Q2 2022 | $51,541,000 | +18.6% | 1,226,005 | +10.0% | 0.07% | +44.0% |
| Q1 2022 | $43,443,000 | +8.1% | 1,115,048 | +10.6% | 0.05% | +2.0% |
| Q4 2021 | $40,183,000 | +11.2% | 1,008,350 | +1.3% | 0.05% | -2.0% |
| Q3 2021 | $36,124,000 | -36.3% | 995,868 | -28.0% | 0.05% | -35.1% |
| Q2 2021 | $56,692,000 | +28.8% | 1,383,073 | +37.1% | 0.08% | +18.5% |
| Q1 2021 | $44,011,000 | -49.0% | 1,008,973 | -41.5% | 0.06% | -4.4% |
| Q4 2020 | $86,300,000 | +270.3% | 1,724,280 | +211.2% | 0.07% | +58.1% |
| Q3 2020 | $23,307,000 | +8.6% | 553,997 | +25.4% | 0.04% | 0.0% |
| Q2 2020 | $21,452,000 | – | 441,851 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |